Back to News
Dec 10, 2025 4:00 PM

STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process

Yunqi Capital Limited, which holds a 5.1% stake in STAAR Surgical Company (NASDAQ:STAA), issued a letter to shareholders on Wednesday.

Staar Surgical shares are sliding. What's pressuring STAA stock?

The letter comes following the close of STAAR's 30-day go-shop period and Alcon Inc.'s (NYSE:ALC) revised acquisition offer of $30.75 per share.

Yunqi reiterated its firm opposition to the deal.

Also Read: New Eye Tech Is Booming For Alcon, Stock Soars

In August, the eye care company Alcon agreed to acquire STAAR Surgical, the manufacturer of the implantable collamer lens, for a total equity value of approximately $1.5 billion.

On Tuesday, Alcon amended the terms to $30.75 per share in cash. This purchase price increase represents an additional approximately $150 ...